Antech highlights a customer who is using technology in unique and/or extraordinary ways. In this edition, we’re taking a look at what Cancer Specialist Dr. Sue Ettinger is doing to help dogs with canine transitional cell carcinoma (TCC), also called urothelial carcinoma (UC), live longer, healthier lives.
Dr. Sue is a strong proponent of CADET® BRAF, a DNA-based diagnostic test that can identify the presence of the single mutation (that is present in 85% of confirmed cases of TCC/UC) to detect disease early.
The CADET BRAF system uses state-of-the-art molecular technology for early detection that is highly accurate (95% sensitivity). It offers a cost-effective, non-invasive way to detect TCC/US early as well monitor a dog’s response to therapy.
Dr. Sue has created a 3-part vlog (video blog) that provides an excellent overview TCC/UC, the standard diagnostic work-up and how she uses CADET BRAF in her practice to help return dogs to good health faster.
“I’m so excited about CADET BRAF: anyone can do it. It’s easy to do, using free-catch urine. It’s a highly sensitive test that’s been validated in hundreds of dogs. And, most importantly, it finds cancer early and you can use it to monitor how treatment is going.”
Get instant access to Dr. Sue Ettinger's 3-part vlog (video blog)
See what's included...
Prevention, causes and early detection of TCC/UC
In this video, Dr Sue will tell you about early detection, risks including high-risk breeds, and things you can do to prevent this cancer.
Using CADET BRAF instead of invasive biopsy to diagnose TCC/UC
In this video, Dr Sue covers diagnostics, including the new non-invasive BRAF mutation test, now exclusively available through Antech Diagnostics.
Treatment options for TCC/UC
In this video, Dr Sue covers treatment options and prognosis.